Feasibility of psychosocial interventions for preventing blood borne virus infection in people who inject drugs

Completed

• Conditions: Blood borne viruses among people who inject drugs; Infections and Infestations

• Registration Number: ISRCTN66453696
• Lead Sponsor: King's College and the Maudsley NHS Foundation Trust (UK)

Brief Summary

2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28320406 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/29208190

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-09-24
• Study Completion: 2016-05-31
• Last Update Posted: 19 March 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

1. PWID are aged 18 and older attending NHS and third sector community addiction and harm reduction clinics and needle exchange programmes (static and mobile)
2. Who have injected drugs at least once in the past 4 weeks
3. Who plan to stay in the area for the next 3 months
4. Who are able to complete the assessment (alone or with help of researcher) and communicate in a group intervention in English.
PWID are not routinely screened for BBV at drug treatment services & therefore do not always know their BBV status. As the focus of the proposed psychosocial intervention will be to increase knowledge about transmission/ reinfection & promote motivation/skills for safer injecting & sex practices, the intervention content will be the same regardless of BBV status.

Exclusion Criteria

PWID who are too intoxicated or in withdrawal to give informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proposed study will examine feasibility and is not powered to determine effect. Differences in number of risk events in past month will be assessed pre, end and 1 month post intervention using intention-to-treat analysis. The Blood Borne Virus Transmission Risk Assessment Questionnaire (TRAQ) will assess the frequency with which PWID have participated in specific injecting, sexual and other risk-practices in the previous month that may expose them to blood-borne viruses. The REDUCE questionnaire on Hepatitis C transmission knowledge and The brief HIV-Knowledge Questionnaire will measure transmission knowledge.

Secondary Outcome Measures

Name	Time	Method
Quality of life will be measured using EQ-5D